Angelini Ventures

The company is building a team focused on health care innovation, solving problems, and delivering impact.

Elia is a founding managing director at Angelini Ventures with over 20 years of executive experience in healthcare and life sciences. He previously held leadership roles at Health Catalyst, Dana-Farber Cancer Institute, and First Star Ventures.

Gabriela is a founding partner at Angelini Ventures with experience in venture capital operations, financial management, talent strategy and communications. Gabriela has over 15 years of experience building and leading finance and human resources teams at global companies.

Paolo is the Chief Executive Officer and Managing Director of Angelini Ventures. He is currently a board member of Argobio, Pretzel Therapeutics, Neumirna, and a member of the investment committee of the Angelini Lumira Bioscience Fund.

Regina is a managing director at Angelini Ventures, leading biotech investments and serving on the boards of ADCytherix, Nuclidium, and a stealth Boston-based rare disease company. She previously led Wellington Partners Life Sciences and represented its funds on several company boards.

Angelini Ventures partners & invests in Digital Health and BioTech, managing €300 million capital to support companies that will shape the future of care.

The privacy policy describes how Angelini Ventures S.p.A. processes data collected through its website and is intended for concerned parties under applicable regulations and Article 13 of EU Regulation 2016/679.